Key Developments
Increasing product development and launches by Integra LifeSciences are expected to aid growth of the global dermal regeneration template market. For instance, in May 2017, Integra LifeSciences Holdings Corporation announced the European launch of its Integra Dermal Regeneration Template (IDRT) Single Layer ‘Thin’, which is an extension of the company’s collagen range of dermal repair products.
Moreover, Integra LifeSciences is also focused on strategic acquisitions in order to expand its product portfolio and revenue. In July 2019, the company announced the acquisition of Arkis Biosciences Inc., a privately-owned company which offers a strong portfolio of neurosurgical devices.
Similarly, the life sciences company is engaged in obtaining strategic investments and funding to strengthen its market position. In August 2019, it was announced that ARP Americas LP invested US$ 302,000 in Integra Lifesciences Holdings Corp. These investments are expected to help the company’s develop, manufacture, and market its surgical implants and medical instruments that have application in neurosurgery, extremity reconstruction, orthopedics, and general surgery.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients